Larvol Delta - Marker-Therapeutics-Announces-FDA-Clearance-of-IND-for-MT601-its-SixAntigen-T-Cell-Therapy-for-the-Treatment-of-Pancreatic-Cancer

MT-601 - Marker Therap

https://finance.yahoo.com/news/marker-therapeutics-announces-fda-clearance-120000726.html

Nov 22, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next